Broggini M - Search Results

1

Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumors to treatment with 5-fluorouracil.

Ganzinelli M, Carrassa L, Crippa F, Tavecchio M, Broggini M, Damia G. Ganzinelli M, et al. Among authors: broggini m. Clin Cancer Res. 2008 Aug 15;14(16):5131-41. doi: 10.1158/1078-0432.CCR-08-0304. Clin Cancer Res. 2008. PMID: 18698031

2

Human ovarian tumors in primary culture: growth, characterization and initial evaluation of the response to cis platinum treatment in vitro.

Balconi G, Broggini M, Erba E, D'Incalci M, Colombo N, Mangioni C, Bertolero F. Balconi G, et al. Among authors: broggini m. Int J Cancer. 1988 Jun 15;41(6):809-18. doi: 10.1002/ijc.2910410606. Int J Cancer. 1988. PMID: 3286530

3

Decreased cytotoxic effects of doxorubicin in a human ovarian cancer-cell line expressing wild-type p53 and WAF1/CIP1 genes.

Vikhanskaya F, D'Incalci M, Broggini M. Vikhanskaya F, et al. Among authors: broggini m. Int J Cancer. 1995 May 4;61(3):397-401. doi: 10.1002/ijc.2910610320. Int J Cancer. 1995. PMID: 7729953

4

Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53.

Vikhanskaya F, Erba E, D'Incalci M, Broggini M. Vikhanskaya F, et al. Among authors: broggini m. Nucleic Acids Res. 1994 Mar 25;22(6):1012-7. doi: 10.1093/nar/22.6.1012. Nucleic Acids Res. 1994. PMID: 8152906 Free PMC article.

5

Sensitivity and cellular response to different anticancer agents of a human ovarian cancer cell line expressing wild-type, mutated or no p53.

Graniela Sirè EA, Vikhanskaya F, Broggini M. Graniela Sirè EA, et al. Among authors: broggini m. Ann Oncol. 1995 Jul;6(6):589-93. doi: 10.1093/oxfordjournals.annonc.a059249. Ann Oncol. 1995. PMID: 8573539 Free article.

6

p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.

Debernardis D, Siré EG, De Feudis P, Vikhanskaya F, Valenti M, Russo P, Parodi S, D'Incalci M, Broggini M. Debernardis D, et al. Among authors: broggini m. Cancer Res. 1997 Mar 1;57(5):870-4. Cancer Res. 1997. PMID: 9041188

7

p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth.

Bonfanti M, Taverna S, Salmona M, D'Incalci M, Broggini M. Bonfanti M, et al. Among authors: broggini m. Cancer Res. 1997 Apr 15;57(8):1442-6. Cancer Res. 1997. PMID: 9108443

8

DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status.

De Feudis P, Debernardis D, Beccaglia P, Valenti M, Graniela Siré E, Arzani D, Stanzione S, Parodi S, D'Incalci M, Russo P, Broggini M. De Feudis P, et al. Among authors: broggini m. Br J Cancer. 1997;76(4):474-9. doi: 10.1038/bjc.1997.412. Br J Cancer. 1997. PMID: 9275024 Free PMC article.

9

Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage.

Vikhanskaya F, Colella G, Valenti M, Parodi S, D'Incalci M, Broggini M. Vikhanskaya F, et al. Among authors: broggini m. Clin Cancer Res. 1999 Apr;5(4):937-41. Clin Cancer Res. 1999. PMID: 10213232

10

Alpha-bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity.

Marchini S, Cirò M, Gallinari F, Geroni C, Cozzi P, D'Incalci M, Broggini M. Marchini S, et al. Among authors: broggini m. Br J Cancer. 1999 Jun;80(7):991-7. doi: 10.1038/sj.bjc.6690453. Br J Cancer. 1999. PMID: 10362106 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters